Vanderbilt University School of
11475 MRB IV
11475 MRB IV 37232-0417
Monoclonal antibodies, Immunology, Infectious disease, Microbiology, Viruses, B cells, Polarized epithelial cells, virus assembly and budding, influenza, dengue, HIV, RSV, MPV, rotavirus, smallpox, vaccinia virus, Ebola virus, Marburg virus. ,Immunology,Infectious disease,Membrane,Microbiology,Molecular medicine,Protein Structure,Structural Biology,Virus
Our laboratory studies focus on the molecular basis for the development of effective B cell responses to viruses in humans, and on the cell biology of virus infection in polarized epithelial cells. We also have active programs in biodefense research, vaccine and monoclonal antibody development, nanomedicine, and biotechnology. Our group uses a very broad array of techniques including molecular and cellular biology, state-of-the-art imaging and flow cytometry, bioinformatics, and bioengineering approaches to attack the scientific problems that are of interest to us. Our philosophy is to work on major human pathogens - we study model systems only when the direct study of the primary pathogen in humans is not feasible at a definitive level. Current studies center on influenza, dengue virus, HIV, respiratory syncytial virus, human metapneumovirus, rotavirus, Rift Valley Fever virus, West Nile virus, and vaccinia virus/smallpox.
A first area of emphasis is the study of the genetic origins and structural determinants of virus neutralizing antibodies. To study this area we have developed unique B cell and antibody engineering techniques including phage display combinatorial libraries, novel methods for generation of human B cell hybridomas, direct cloning of antibody variable genes from virus-specific B cells, human hybridoma methods, high throughput sequence analysis, and full-length expression of recombinant antibodies. This work has allowed us to understand better structure/function characteristics of antiviral antibodies. Several of the recombinant human antibodies that we have generated are being developed commercially.
We have a second major program in the study of the trafficking of virus proteins in polarized epithelial cells. We have recently discovered that a unique cell compartment, the apical recycling endosome, controls directional budding of respiratory syncytial virus. We are studying the role of particular proteins, including Rabs, Rab-FIPs, and myosins on viral trafficking. We also have investigated the role of stress granules in RSV infection. Currently, scientists are exploring the role of viral proteins in controlling these processes. This work requires careful biochemistry, confocal and electron microscopy, and molecular biology.
Immunology and Cell Biology of Virus Infection in Humans
Immunology of infectious diseases. Infant respiratory virus infections due to RSV and metapneumovirus.
Aiyegbo, MS, Eli, IM, Spiller, BW, Williams, DR, Kim, R, Lee, DE, Liu, T, Li, S, Stewart, PL, Crowe, JE. Differential Accessibility of a Rotavirus VP6 Epitope in Trimers Comprising Type I, II, or III Channels as Revealed by Binding of a Human Rotavirus VP6-Specific Antibody. J Virol, 88(1), 469-76, 2014.
Almagro, JC, Gilliland, GL, Breden, F, Scott, JK, Sok, D, Pauthner, M, Reichert, JM, Helguera, G, Andrabi, R, Mabry, R, Bl??ry, M, Voss, JE, Laur??n, J, Abuqayyas, L, Barghorn, S, Ben-Jacob, E, Crowe, JE, Huston, JS, Johnston, SA, Krauland, E, Lund-Johansen, F, Marasco, WA, Parren, PW, Xu, KY. Antibody Engineering and Therapeutics: December 8-12, 2013, Huntington Beach, CA. MAbs, 6(3), 577-618, 2014.
Alonas, E, Lifland, AW, Gudheti, M, Vanover, D, Jung, J, Zurla, C, Kirschman, J, Fiore, VF, Douglas, A, Barker, TH, Yi, H, Wright, ER, Crowe, JE, Santangelo, PJ. Combining single RNA sensitive probes with subdiffraction-limited and live-cell imaging enables the characterization of virus dynamics in cells. ACS Nano, 8(1), 302-15, 2014.
Bates, JT, Keefer, CJ, Slaughter, JC, Kulp, DW, Schief, WR, Crowe, JE. Escape from neutralization by the respiratory syncytial virus-specific neutralizing monoclonal antibody palivizumab is driven by changes in on-rate of binding to the fusion protein. Virology, 454-455, 139-44, 2014.
Correia, BE, Bates, JT, Loomis, RJ, Baneyx, G, Carrico, C, Jardine, JG, Rupert, P, Correnti, C, Kalyuzhniy, O, Vittal, V, Connell, MJ, Stevens, E, Schroeter, A, Chen, M, Macpherson, S, Serra, AM, Adachi, Y, Holmes, MA, Li, Y, Klevit, RE, Graham, BS, Wyatt, RT, Baker, D, Strong, RK, Crowe, JE, Johnson, PR, Schief, WR. Proof of principle for epitope-focused vaccine design. Nature, 507(7491), 201-6, 2014.
Fibriansah, G, Tan, JL, Smith, SA, de Alwis, AR, Ng, TS, Kostyuchenko, VA, Ibarra, KD, Wang, J, Harris, E, de Silva, A, Crowe, JE, Lok, SM. A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface. EMBO Mol Med, 6(3), 358-71, 2014.
Messer, WB, de Alwis, R, Yount, BL, Royal, SR, Huynh, JP, Smith, SA, Crowe, JE, Doranz, BJ, Kahle, KM, Pfaff, JM, White, LJ, Sariol, CA, de Silva, AM, Baric, RS. Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity. Proc Natl Acad Sci U S A, 111(5), 1939-44, 2014.
Aiyegbo, MS, Sapparapu, G, Spiller, BW, Eli, IM, Williams, DR, Kim, R, Lee, DE, Liu, T, Li, S, Woods, VL, Nannemann, DP, Meiler, J, Stewart, PL, Crowe, JE. Human rotavirus VP6-specific antibodies mediate intracellular neutralization by binding to a quaternary structure in the transcriptional pore. PLoS One, 8(5), e61101, 2013.
Bates, JT, Keefer, CJ, Utley, TJ, Correia, BE, Schief, WR, Crowe, JE. Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency. J Immunol, 190(7), 3732-9, 2013.
Crowe, JE. Immunology. Crowdsourcing immunity. Science, 340(6133), 692-3, 2013.
Crowe, JE. Universal flu vaccines: primum non nocere. Sci Transl Med, 5(200), 200fs34, 2013.
Finn, JA, Crowe, JE. Impact of new sequencing technologies on studies of the human B cell repertoire. Curr Opin Immunol, 25(5), 613-8, 2013.
Gilchuk, P, Spencer, CT, Conant, SB, Hill, T, Gray, JJ, Niu, X, Zheng, M, Erickson, JJ, Boyd, KL, McAfee, KJ, Oseroff, C, Hadrup, SR, Bennink, JR, Hildebrand, W, Edwards, KM, Crowe, JE, Williams, JV, Buus, S, Sette, A, Schumacher, TN, Link, AJ, Joyce, S. Discovering naturally processed antigenic determinants that confer protective T cell immunity. J Clin Invest, 123(5), 1976-87, 2013.
Hartman, ML, Xu, R, Crowe, BJ, Robison, LL, Erfurth, EM, Kleinberg, DL, Zimmermann, AG, Woodmansee, WW, Cutler, GB, Chipman, JJ, Melmed, S, , . Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients. J Clin Endocrinol Metab, 98(3), 980-8, 2013.
Hong, M, Lee, PS, Hoffman, RM, Zhu, X, Krause, JC, Laursen, NS, Yoon, SI, Song, L, Tussey, L, Crowe, JE, Ward, AB, Wilson, IA. Antibody recognition of the pandemic H1N1 Influenza virus hemagglutinin receptor binding site. J Virol, 87(22), 12471-80, 2013.
Munden, MM, Williams, JL, Zhang, W, Crowe, JE, Munden, RF, Cisek, LJ. Intermittent testicular torsion in the pediatric patient: sonographic indicators of a difficult diagnosis. AJR Am J Roentgenol, 201(4), 912-8, 2013.
Sapparapu, G, Sims, AL, Aiyegbo, MS, Shaikh, FY, Harth, EM, Crowe, JE. Intracellular neutralization of a virus using a cell-penetrating molecular transporter. Nanomedicine (Lond), , , 2013.
Shaikh, FY, Crowe, JE. Molecular mechanisms driving respiratory syncytial virus assembly. Future Microbiol, 8(1), 123-31, 2013.
Smith, SA, de Alwis, AR, Kose, N, Harris, E, Ibarra, KD, Kahle, KM, Pfaff, JM, Xiang, X, Doranz, BJ, de Silva, AM, Austin, SK, Sukupolvi-Petty, S, Diamond, MS, Crowe, JE. The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein. MBio, 4(6), e00873-13, 2013.
Smith, SA, de Alwis, R, Kose, N, Durbin, AP, Whitehead, SS, de Silva, AM, Crowe, JE. Human monoclonal antibodies derived from memory B cells following live attenuated dengue virus vaccination or natural infection exhibit similar characteristics. J Infect Dis, 207(12), 1898-908, 2013.
Stone, JW, Thornburg, NJ, Blum, DL, Kuhn, SJ, Wright, DW, Crowe, JE. Gold nanorod vaccine for respiratory syncytial virus. Nanotechnology, 24(29), 295102, 2013.
Thornburg, NJ, Nannemann, DP, Blum, DL, Belser, JA, Tumpey, TM, Deshpande, S, Fritz, GA, Sapparapu, G, Krause, JC, Lee, JH, Ward, AB, Lee, DE, Li, S, Winarski, KL, Spiller, BW, Meiler, J, Crowe, JE. Human antibodies that neutralize respiratory droplet transmissible H5N1 influenza viruses. J Clin Invest, 123(10), 4405-9, 2013.
Willis, JR, Briney, BS, DeLuca, SL, Crowe, JE, Meiler, J. Human germline antibody gene segments encode polyspecific antibodies. PLoS Comput Biol, 9(4), e1003045, 2013.
Xu, R, Krause, JC, McBride, R, Paulson, JC, Crowe, JE, Wilson, IA. A recurring motif for antibody recognition of the receptor-binding site of influenza hemagglutinin. Nat Struct Mol Biol, 20(3), 363-70, 2013.
Briney, BS, Willis, JR, Crowe, JE. Location and length distribution of somatic hypermutation-associated DNA insertions and deletions reveals regions of antibody structural plasticity. Genes Immun, , , 2012. PMCID:3396619
Briney, BS, Willis, JR, Crowe, JE. Human peripheral blood antibodies with long HCDR3s are established primarily at original recombination using a limited subset of germline genes. PLoS One, 7(5), e36750, 2012. PMCID:3348910
Briney, BS, Willis, JR, Hicar, MD, Thomas, JW, Crowe, JE. Frequency and genetic characterization of V(DD)J recombinants in the human peripheral blood antibody repertoire. Immunology, 137(1), 56-64, 2012. PMCID:3396619
Briney, BS, Willis, JR, McKinney, BA, Crowe, JE. High-throughput antibody sequencing reveals genetic evidence of global regulation of the na??ve and memory repertoires that extends across individuals. Genes Immun, , , 2012. PMCID:3396619
Crowe, JE. Influenza virus resistance to human neutralizing antibodies. MBio, 3(4), , 2012.
Engelhardt, BG, Jagasia, SM, Crowe, JE, Griffith, ML, Savani, BN, Kassim, AA, Lu, P, Weitkamp, JH, Moore, DJ, Yoder, SM, Rock, MT, Jagasia, M. Predicting posttransplantation diabetes mellitus by regulatory T-cell phenotype: implications for metabolic intervention to modulate alloreactivity. Blood, 119(10), 2417-21, 2012. PMCID:3280462
Engelhardt, BG, Sengsayadeth, SM, Jagasia, M, Savani, BN, Kassim, AA, Lu, P, Shyr, Y, Yoder, SM, Rock, MT, Crowe, JE. Tissue-specific regulatory T cells; biomarker for acute graft-versus-host disease and survival. Exp Hematol, , , 2012.
Krause, JC, Tsibane, T, Tumpey, TM, Huffman, CJ, Albrecht, R, Blum, DL, Ramos, I, Fernandez-Sesma, A, Edwards, KM, Garc?-a-Sastre, A, Basler, CF, Crowe, JE. Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses. J Virol, 86(11), 6334-40, 2012. PMCID:3348910
Shaikh, FY, Cox, RG, Lifland, AW, Hotard, AL, Williams, JV, Moore, ML, Santangelo, PJ, Crowe, JE. A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles. MBio, 3(1), , 2012. PMCID:3280462
Shaikh, FY, Utley, TJ, Craven, RE, Rogers, MC, Lapierre, LA, Goldenring, JR, Crowe, JE. Respiratory syncytial virus assembles into structured filamentous virion particles independently of host cytoskeleton and related proteins. PLoS One, 7(7), e40826, 2012. PMCID:3396619
Smith, SA, Zhou, Y, Olivarez, NP, Broadwater, AH, de Silva, AM, Crowe, JE. Persistence of circulating memory B cell clones with potential for dengue virus disease enhancement for decades following infection. J Virol, 86(5), 2665-75, 2012. PMCID:3280462
Thornburg, NJ, Hayward, SL, Crowe, JE. Respiratory syncytial virus regulates human microRNAs by using mechanisms involving beta interferon and NF-??B. MBio, 3(6), , 2012.
Joyner, AS, Willis, JR, Crowe, JE, Aiken, C. Maturation-induced cloaking of neutralization epitopes on HIV-1 particles. PLoS Pathog, 7(9), e1002234, 2011. PMCID:3169560
Krause, JC, Ekiert, DC, Tumpey, TM, Smith, PB, Wilson, IA, Crowe, JE. An insertion mutation that distorts antibody binding site architecture enhances function of a human antibody. MBio, 2(1), e00345-10, 2011. PMCID:3037006
Krause, JC, Tsibane, T, Tumpey, TM, Huffman, CJ, Basler, CF, Crowe, JE. A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. J Virol, 85(20), 10905-8, 2011. PMCID:3169560
Krause, JC, Tsibane, T, Tumpey, TM, Huffman, CJ, Briney, BS, Smith, SA, Basler, CF, Crowe, JE. Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence. J Immunol, 187(7), 3704-11, 2011. PMCID:3169560
Lindquist, ME, Mainou, BA, Dermody, TS, Crowe, JE. Activation of protein kinase R is required for induction of stress granules by respiratory syncytial virus but dispensable for viral replication. Virology, 413(1), 103-10, 2011.
Rock, MT, McKinney, BA, Yoder, SM, Prudom, CE, Wright, DW, Crowe, JE. Identification of potential human respiratory syncytial virus and metapneumovirus T cell epitopes using computational prediction and MHC binding assays. J Immunol Methods, 374(1-2), 13-7, 2011. PMCID:3169560
Engelhardt, BG, Crowe, JE. Homing in on Acute Graft vs. Host Disease: Tissue-Specific T Regulatory and Th17 Cells. Curr Top Microbiol Immunol, , , 2010.
Engelhardt, BG, Jagasia, M, Savani, BN, Bratcher, NL, Greer, JP, Jiang, A, Kassim, AA, Lu, P, Schuening, F, Yoder, SM, Rock, MT, Crowe, JE. Regulatory T cell expression of CLA or alpha(4)beta(7) and skin or gut acute GVHD outcomes. Bone Marrow Transplant, , , 2010.
Hicar, MD, Chen, X, Briney, B, Hammonds, J, Wang, JJ, Kalams, S, Spearman, PW, Crowe, JE. Pseudovirion particles bearing native HIV envelope trimers facilitate a novel method for generating human neutralizing monoclonal antibodies against HIV. J Acquir Immune Defic Syndr, 54(3), 223-35, 2010.
Hicar, MD, Kalams, SA, Spearman, PW, Crowe, JE. Emerging studies of human HIV-specific antibody repertoires. Vaccine, 28 Suppl 2, B18-23, 2010.
Krause, JC, Tumpey, TM, Huffman, CJ, McGraw, PA, Pearce, MB, Tsibane, T, Hai, R, Basler, CF, Crowe, JE. Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. J Virol, 84(6), 3127-30, 2010.
Lindquist, ME, Lifland, AW, Utley, TJ, Santangelo, PJ, Crowe, JE. Respiratory syncytial virus induces host RNA stress granules to facilitate viral replication. J Virol, 84(23), 12274-84, 2010. PMCID:2976418
Pishchany, G, McCoy, AL, Torres, VJ, Krause, JC, Crowe, JE, Fabry, ME, Skaar, EP. Specificity for human hemoglobin enhances Staphylococcus aureus infection. Cell Host Microbe, 8(6), 544-50, 2010. PMCID:3037006
Thornburg, NJ, Shepherd, B, Crowe, JE. Transforming growth factor beta is a major regulator of human neonatal immune responses following respiratory syncytial virus infection. J Virol, 84(24), 12895-902, 2010. PMCID:3004333
Williams, JV, Edwards, KM, Weinberg, GA, Griffin, MR, Hall, CB, Zhu, Y, Szilagyi, PG, Wang, CK, Yang, CF, Silva, D, Ye, D, Spaete, RR, Crowe, JE. Population-based incidence of human metapneumovirus infection among hospitalized children. J Infect Dis, 201(12), 1890-8, 2010.
Xu, R, Ekiert, DC, Krause, JC, Hai, R, Crowe, JE, Wilson, IA. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science, 328(5976), 357-60, 2010.
Crowe, JE. Recent advances in the study of human antibody responses to influenza virus using optimized human hybridoma approaches. Vaccine, 27 Suppl 6, G47-51, 2009.
Moore, ML, Chi, MH, Luongo, C, Lukacs, NW, Polosukhin, VV, Huckabee, MM, Newcomb, DC, Buchholz, UJ, Crowe, JE, Goleniewska, K, Williams, JV, Collins, PL, Peebles, RS. A Chimeric A2 Strain Respiratory Syncytial Virus (RSV) with the Fusion Protein of RSV Strain Line 19 Exhibits Enhanced Viral Load, Mucus, and Airway Dysfunction. J Virol, , , 2009. PMCID:2668460
Talbot, HK, Crowe, JE, Edwards, KM, Griffin, MR, Zhu, Y, Weinberg, GA, Szilagyi, PG, Hall, CB, Podsiad, AB, Iwane, M, Williams, JV, , . Coronavirus infection and hospitalizations for acute respiratory illness in young children. J Med Virol, 81(5), 853-6, 2009. PMCID:2767383
Talbot, HK, Shepherd, BE, Crowe, JE, Griffin, MR, Edwards, KM, Podsiad, AB, Tollefson, SJ, Wright, PF, Williams, JV. The pediatric burden of human coronaviruses evaluated for twenty years. Pediatr Infect Dis J, 28(8), 682-7, 2009. PMCID:2765860
Yang, CF, Wang, CK, Tollefson, SJ, Piyaratna, R, Lintao, LD, Chu, M, Liem, A, Mark, M, Spaete, RR, Crowe, JE, Williams, JV. Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years. Virol J, 6, 138, 2009. PMCID:2753315
Derdowski, A, Peters, TR, Glover, N, Qian, R, Utley, TJ, Burnett, A, Williams, JV, Spearman, P, Crowe, JE. Human metapneumovirus nucleoprotein and phosphoprotein interact and provide the minimal requirements for inclusion body formation. J Gen Virol, 89(Pt 11), 2698-708, 2008.
Kallewaard, NL, McKinney, BA, Gu, Y, Chen, A, Prasad, BV, Crowe, JE. Functional maturation of the human antibody response to rotavirus. J Immunol, 180(6), 3980-9, 2008.
Mok, H, Lee, S, Wright, DW, Crowe, JE. Enhancement of the CD8(+) T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope. Vaccine, , , 2008. PMCID:2561208
Mok, H, Tollefson, SJ, Podsiad, AB, Shepherd, BE, Polosukhin, VV, Johnston, RE, Williams, JV, Crowe, JE. An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats. J Virol, 82(22), 11410-8, 2008. PMCID:2573258
Tian, C, Luskin, GK, Dischert, KM, Higginbotham, JN, Shepherd, BE, Crowe, JE. Immunodominance of the VH1-46 antibody gene segment in the primary repertoire of human rotavirus-specific B cells is reduced in the memory compartment through somatic mutation of nondominant clones. J Immunol, 180(5), 3279-88, 2008.
Utley, TJ, Ducharme, NA, Varthakavi, V, Shepherd, BE, Santangelo, PJ, Lindquist, ME, Goldenring, JR, Crowe, JE. Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc Natl Acad Sci U S A, 105(29), 10209-14, 2008. PMCID:2481327
Yu, X, McGraw, PA, House, FS, Crowe, JE. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. J Immunol Methods, 336(2), 142-51, 2008. PMCID:2519117
Yu, X, Tsibane, T, McGraw, PA, House, FS, Keefer, CJ, Hicar, MD, Tumpey, TM, Pappas, C, Perrone, LA, Martinez, O, Stevens, J, Wilson, IA, Aguilar, PV, Altschuler, EL, Basler, CF, Crowe, JE. Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors. Nature, 455(7212), 532-6, 2008.
Cseke, G, Wright, DW, Tollefson, SJ, Johnson, JE, Crowe, JE, Williams, JV. Human metapneumovirus fusion protein vaccines that are immunogenic and protective
in cotton rats. J Virol, 81(2), 698-707, 2007. PMCID:1797435
Miller, SA, Tollefson, S, Crowe, JE, Williams, JV, Wright, DW. Examination of a fusogenic hexameric core from human metapneumovirus and identification
of a potent synthetic peptide inhibitor from the heptad repeat 1 region. J Virol, 81(1), 141-9, 2007. PMCID:1797239
Mok, H, Lee, S, Utley, TJ, Shepherd, BE, Polosukhin, VV, Collier, ML, Davis, NL, Johnston, RE, Crowe, JE. Venezuelan Equine Encephalitis Replicon Particles Encoding Respiratory Syncytial Virus Surface Glycoproteins Induce Protective Mucosal Responses in Mice and Cotton Rats. J Virol, , , 2007. PMCID:2168850
Tian, C, Luskin, GK, Dischert, KM, Higginbotham, JN, Shepherd, BE, Crowe, JE. Evidence for preferential Ig gene usage and differential TdT and exonuclease
activities in human na??ve and memory B cells. Mol Immunol, 44(9), 2173-83, 2007. PMCID:1859862
Williams, JV, Chen, Z, Cseke, G, Wright, DW, Keefer, CJ, Tollefson, SJ, Hessell, A, Podsiad, A, Shepherd, BE, Sanna, PP, Burton, DR, Crowe, JE, Williamson, RA. A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo. J Virol, 81(15), 8315-24, 2007. PMCID:1951312
Lee, S, Miller, SA, Wright, DW, Rock, MT, Crowe, JE. Tissue-Specific Regulation of CD8+ T Lymphocyte Immunodominance in Respiratory
Syncytial Virus Infection. J Virol, , , 2006. PMCID:1865932
McKinney, BA, Crowe, JE, Voss, HU, Crooke, PS, Barney, N, Moore, JH. Hybrid grammar-based approach to nonlinear dynamical system identification
from biological time series. Phys Rev E Stat Nonlin Soft Matter Phys, 73(2 Pt 1), 021912, 2006.
McKinney, BA, Reif, DM, Rock, MT, Edwards, KM, Kingsmore, SF, Moore, JH, Crowe, JE. Cytokine expression patterns associated with systemic adverse events following
smallpox immunization. J Infect Dis, 194(4), 444-53, 2006. PMCID:1620015
Rock, MT, Yoder, SM, Talbot, TR, Edwards, KM, Crowe, JE. Cellular immune responses to diluted and undiluted aventis pasteur smallpox
vaccine. J Infect Dis, 194(4), 435-43, 2006.
Tian, C, Kron, GK, Dischert, KM, Higginbotham, JN, Crowe, JE. Low expression of the interleukin (IL)-4 receptor alpha chain and reduced signalling
via the IL-4 receptor complex in human neonatal B cells. Immunology, 119(1), 54-62, 2006. PMCID:1782340
Williams, JV, Wang, CK, Yang, CF, Tollefson, SJ, House, FS, Heck, JM, Chu, M, Brown, JB, Lintao, LD, Quinto, JD, Chu, D, Spaete, RR, Edwards, KM, Wright, PF, Crowe, JE. The role of human metapneumovirus in upper respiratory tract infections in
children: a 20-year experience. J Infect Dis, 193(3), 387-95, 2006. PMCID:1586246
Bentzen, EL, House, F, Utley, TJ, Crowe, JE, Wright, DW. Progression of respiratory syncytial virus infection monitored by fluorescent
quantum dot probes. Nano Lett, 5(4), 591-5, 2005.
Bowen, AL, Tian, C, LaFleur, BJ, Crowe, JE. Transcriptional control of activation-induced cytidine deaminase and error-prone
DNA polymerases is functionally mature in the B cells of infants at birth. Hum Immunol, 67(1-2), 43-6, 2005.
Brock, SC, Heck, JM, McGraw, PA, Crowe, JE. The transmembrane domain of the respiratory syncytial virus F protein is an
orientation-independent apical plasma membrane sorting sequence. J Virol, 79(19), 12528-35, 2005. PMCID:1211512
Chen, X, Rock, MT, Hammonds, J, Tartaglia, J, Shintani, A, Currier, J, Slike, B, Crowe, JE, Marovich, M, Spearman, P. Pseudovirion particle production by live poxvirus human immunodeficiency virus
vaccine vector enhances humoral and cellular immune responses. J Virol, 79(9), 5537-47, 2005. PMCID:1082749
Kallewaard, NL, Bowen, AL, Crowe, JE. Cooperativity of actin and microtubule elements during replication of respiratory
syncytial virus. Virology, 331(1), 73-81, 2005.
Rock, MT, Yoder, SM, Wright, PF, Talbot, TR, Edwards, KM, Crowe, JE. Differential regulation of granzyme and perforin in effector and memory T cells
following smallpox immunization. J Immunol, 174(6), 3757-64, 2005.
Shaklee, JF, Talbot, TR, Muldowney, JA, Vaughan, DE, Butler, J, House, F, Crowe, JE, Smith, LH, Edwards, KM. Smallpox vaccination does not elevate systemic levels of prothrombotic proteins
associated with ischemic cardiac events. J Infect Dis, 191(5), 724-30, 2005.
Tai, JH, Williams, JV, Edwards, KM, Wright, PF, Crowe, JE, Dermody, TS. Prevalence of reovirus-specific antibodies in young children in nashville,
tennessee. J Infect Dis, 191(8), 1221-4, 2005.
Weitkamp, JH, Kallewaard, NL, Bowen, AL, Lafleur, BJ, Greenberg, HB, Crowe, JE. VH1-46 is the dominant immunoglobulin heavy chain gene segment in rotavirus-specific
memory B cells expressing the intestinal homing receptor alpha4beta7. J Immunol, 174(6), 3454-60, 2005.
Weitkamp, JH, Lafleur, BJ, Crowe, JE. Rotavirus-specific CD5+ B cells in young children exhibit a distinct antibody
repertoire compared with CD5- B cells. Hum Immunol, 67(1-2), 33-42, 2005.
Weitkamp, JH, Lafleur, BJ, Greenberg, HB, Crowe, JE. Natural evolution of a human virus-specific antibody gene repertoire by somatic
hypermutation requires both hotspot-directed and randomly-directed processes. Hum Immunol, 66(6), 666-76, 2005.
Williams, JV, Crowe, JE, Enriquez, R, Minton, P, Peebles, RS, Hamilton, RG, Higgins, S, Griffin, M, Hartert, TV. Human metapneumovirus infection plays an etiologic role in acute asthma exacerbations
requiring hospitalization in adults. J Infect Dis, 192(7), 1149-53, 2005. PMCID:1476781
Williams, JV, Martino, R, Rabella, N, Otegui, M, Parody, R, Heck, JM, Crowe, JE. A prospective study comparing human metapneumovirus with other respiratory
viruses in adults with hematologic malignancies and respiratory tract infections. J Infect Dis, 192(6), 1061-5, 2005. PMCID:1483060
Williams, JV, Tollefson, SJ, Johnson, JE, Crowe, JE. The cotton rat (Sigmodon hispidus) is a permissive small animal model of human
metapneumovirus infection, pathogenesis, and protective immunity. J Virol, 79(17), 10944-51, 2005. PMCID:1193579
Crowe, JE. Human metapneumovirus as a major cause of human respiratory tract disease. Pediatr Infect Dis J, 23(11 Suppl), S215-21, 2004.
Rock, Michael T, Yoder, Sandra M, Talbot, Thomas R, Edwards, Kathryn M, Crowe, James E. Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels. J Infect Dis, 189(8), 1401-10, 2004.
Suara, Rahaman O, Crowe, James E. Effect of zinc salts on respiratory syncytial virus replication. Antimicrob Agents Chemother, 48(3), 783-90, 2004. PMCID:353050
Talbot, TR, Stapleton, JT, Brady, RC, Winokur, PL, Bernstein, DI, Germanson, T, Yoder, SM, Rock, MT, Crowe, JE, Edwards, KM. Vaccination success rate and reaction profile with diluted and undiluted smallpox
vaccine: a randomized controlled trial. JAMA, 292(10), 1205-12, 2004.
Williams, John V, Harris, Paul A, Tollefson, Sharon J, Halburnt-Rush, Lisa L, Pingsterhaus, Joyce M, Edwards, Kathryn M, Wright, Peter F, Crowe, James E. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N Engl J Med, 350(5), 443-50, 2004. PMCID:1831873
Crowe JE Jr., Lawton AR. "Ontogeny of Immunity". Chapter 1 of Immunologic Disorders in Infants and Children, 5th ed, in press
Brock, Sean C, Goldenring, James R, Crowe, James E. Apical recycling systems regulate directional budding of respiratory syncytial virus from polarized epithelial cells. Proc Natl Acad Sci U S A, 100(25), 15143-8, 2003. PMCID:299925
Crowe, James E, Williams, John V. Immunology of viral respiratory tract infection in infancy. Paediatr Respir Rev, 4, 112-9, 2003.
Crowe, James E., Sannella, Edith C., Pfeiffer, Steffen, Zorn, George L., Azimzadeh, Agnes, Newman, Roland, Miller, Geraldine G., Pierson, Richard N. CD154 Regulates Primate Humoral Immunity to Influenza. Am J Transplant, 3, 680-688, 2003.
Halasa, Natasha B, Whitlock, James A, McCurley, Thomas L, Smith, Jarrod A, Zhu, Quili, Ochs, Hans, Dermody, Terence S, Crowe, James E. Fatal hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection in a patient with a novel mutation in the signaling lymphocytic activation molecule-associated protein. Clin Infect Dis, 37(10), e136-41, 2003.
Rock, Michael T, Crowe, James E. Identification of a novel human leucocyte antigen-A*01-restricted cytotoxic T-lymphocyte epitope in the respiratory syncytial virus fusion protein. Immunology, 108, 474-80, 2003. PMCID:1782928
Venter, Marietjie, Rock, Michael, Puren, Adrian J, Tiemessen, Caroline T, Crowe, James E. Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains. J Virol, 77(13), 7319-29, 2003. PMCID:164818
Weitkamp, Joern-Hendrik, Kallewaard, Nicole, Kusuhara, Koichi, Bures, Elizabeth, Williams, John V, LaFleur, Bonnie, Greenberg, Harry B, Crowe, James E. Infant and adult human B cell responses to rotavirus share common immunodominant variable gene repertoires. J Immunol, 171(9), 4680-8, 2003.
Weitkamp, J??rn Hendrik, Kallewaard, Nicole, Kusuhara, Koichi, Feigelstock, Dino, Feng, Ninguo, Greenberg, Harry B, Crowe, James E. Generation of recombinant human monoclonal antibodies to rotavirus from single antigen-specific B cells selected with fluorescent virus-like particles. J Immunol Methods, 275, 223-37, 2003.
Crowe JE Jr, Englund JA. Future Strategies for Prevention of Respiratory Syncytial Virus Infection, in Contemporary Diagnosis and Management of Respiratory Syncytial Virus Infection, eds. Weisman LE and Groothuis JR, 2000.
Brock, Sean C, McGraw, Patricia A, Wright, Peter F, Crowe, James E. The human polymeric immunoglobulin receptor facilitates invasion of epithelial cells by Streptococcus pneumoniae in a strain-specific and cell type-specific manner. Infect Immun, 70, 5091-5, 2002. PMCID:128237
Peters, Timothy R, Jennings, Mark T, Crowe, James E. Pneumocystis carinii pneumonia in a girl with a midbrain glioma. Pediatr Hematol Oncol, 19(2), 141-3, 2002.
Crowe, J E. Respiratory syncytial virus vaccine development. Vaccine, 20 Suppl 1, S32-7, 2001.
Crowe, J E. Influence of maternal antibodies on neonatal immunization against respiratory viruses. Clin Infect Dis, 33(10), 1720-7, 2001.
Crowe, J E, Firestone, C Y, Murphy, B R. Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines. J Immunol, 167(7), 3910-8, 2001.
Crowe, J E, Suara, R O, Brock, S, Kallewaard, N, House, F, Weitkamp, J H. Genetic and structural determinants of virus neutralizing antibodies. Immunol Res, 23(2-3), 135-45, 2001.
Pierson, R N, Crowe, J E, Pfeiffer, S, Atkinson, J, Azimzadeh, A, Miller, G G. CD40-ligand in primate cardiac allograft and viral immunity. Immunol Res, 23(2-3), 253-62, 2001.
Weitkamp, J H, Crowe, J E. Blood donor leukocyte reduction filters as a source of human B lymphocytes. Biotechniques, 31(3), 464, 466, 2001.
Pastey, M K, Gower, T L, Spearman, P W, Crowe, J E, Graham, B S. A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3. Nat Med, 6(1), 35-40, 2000.
Peters, T R, Brumbaugh, D E, Lawton, A R, Crowe, J E. Recurrent pneumococcal arthritis as the presenting manifestation of X-linked agammaglobulinemia. Clin Infect Dis, 31(5), 1287-8, 2000.
Weitkamp J-H, Crowe JE Jr. Current approaches to vaccine development against disease caused by respiratory syncytial virus (RSV). Monatsschr Kinderheilkd, 148, 980-989, 2000.
Weitkamp, J H, Tang, Y W, Haas, D W, Midha, N K, Crowe, J E. Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome. Clin Infect Dis, 31(5), 1183-7, 2000.
Wright, P F, Karron, R A, Belshe, R B, Thompson, J, Crowe, J E, Boyce, T G, Halburnt, L L, Reed, G W, Whitehead, S S, Anderson, E L, Wittek, A E, Casey, R, Eichelberger, M, Thumar, B, Randolph, V B, Udem, S A, Chanock, R M, Murphy, B R. Evaluation of a live, cold-passaged, temperature-sensitive, respiratory syncytial virus vaccine candidate in infancy. J Infect Dis, 182(5), 1331-42, 2000.
Crowe JE Jr, Randolph V, Murphy BR. The live attenuated
subgroup B respiratory syncytial virus vaccine candidate
RSV 2B33F is attenuated and immunogenic in chimpanzees,
but exhibits partial loss of the ts phenotype following
replication in vivo. Virus Research, 59, 13-22, 1999.
Crowe, J E. Host responses to respiratory virus infection and immunization. Curr Top Microbiol Immunol, 236, 191-214, 1999.
Crowe, J E, Randolph, V, Murphy, B R. The live attenuated subgroup B respiratory syncytial virus vaccine candidate RSV 2B33F is attenuated and immunogenic in chimpanzees, but exhibits partial loss of the ts phenotype following replication in vivo. Virus Res, 59(1), 13-22, 1999.
Fisher, R G, Crowe, J E, Johnson, T R, Tang, Y W, Graham, B S. Passive IgA monoclonal antibody is no more effective than IgG at protecting mice from mucosal challenge with respiratory syncytial virus. J Infect Dis, 180(4), 1324-7, 1999.
Pastey, M K, Crowe, J E, Graham, B S. RhoA interacts with the fusion glycoprotein of respiratory syncytial virus and facilitates virus-induced syncytium formation. J Virol, 73(9), 7262-70, 1999. PMCID:104251
Sakurai, H, Williamson, R A, Crowe, J E, Beeler, J A, Poignard, P, Bastidas, R B, Chanock, R M, Burton, D R. Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines. J Virol, 73(4), 2956-62, 1999. PMCID:104055
Whitehead, S S, Firestone, C Y, Karron, R A, Crowe, J E, Elkins, W R, Collins, P L, Murphy, B R. Addition of a missense mutation present in the L gene of respiratory syncytial virus (RSV) cpts530/1030 to RSV vaccine candidate cpts248/404 increases its attenuation and temperature sensitivity. J Virol, 73(2), 871-7, 1999. PMCID:103906
Crowe, J E. Immune responses of infants to infection with respiratory viruses and live attenuated respiratory virus candidate vaccines. Vaccine, 16(14-15), 1423-32, 1998.
Crowe, J E, Firestone, C Y, Crim, R, Beeler, J A, Coelingh, K L, Barbas, C F, Burton, D R, Chanock, R M, Murphy, B R. Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein. Virology, 252(2), 373-5, 1998.
Crowe, J E, Gilmour, P S, Murphy, B R, Chanock, R M, Duan, L, Pomerantz, R J, Pilkington, G R. Isolation of a second recombinant human respiratory syncytial virus monoclonal antibody fragment (Fab RSVF2-5) that exhibits therapeutic efficacy in vivo. J Infect Dis, 177(4), 1073-6, 1998.
Crowe JE Jr, Murphy BR. Vaccines against respiratory syncytial virus and parainfluenza type 3. New Generation Vaccines, 2nd ed, Levine MM, Woodrow GC, Kaper JB, Cobon GS, , 711-725, 1997.
Juhasz, K, Whitehead, S S, Bui, P T, Biggs, J M, Crowe, J E, Boulanger, C A, Collins, P L, Murphy, B R. The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein. J Virol, 71(8), 5814-9, 1997. PMCID:191836
Karron, R A, Wright, P F, Crowe, J E, Clements-Mann, M L, Thompson, J, Makhene, M, Casey, R, Murphy, B R. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. J Infect Dis, 176(6), 1428-36, 1997.
Crowe JE Jr. The role of antibodies in respiratory viral immunity. Seminars in Virology, 7, 273-283, 1996.
Crowe, J E, Bui, P T, Firestone, C Y, Connors, M, Elkins, W R, Chanock, R M, Murphy, B R. Live subgroup B respiratory syncytial virus vaccines that are attenuated, genetically stable, and immunogenic in rodents and nonhuman primates. J Infect Dis, 173(4), 829-39, 1996.
Crowe, J E, Firestone, C Y, Whitehead, S S, Collins, P L, Murphy, B R. Acquisition of the ts phenotype by a chemically mutagenized cold-passaged human respiratory syncytial virus vaccine candidate results from the acquisition of a single mutation in the polymerase (L) gene. Virus Genes, 13(3), 269-73, 1996.
Firestone, C Y, Whitehead, S S, Collins, P L, Murphy, B R, Crowe, J E. Nucleotide sequence analysis of the respiratory syncytial virus subgroup A cold-passaged (cp) temperature sensitive (ts) cpts-248/404 live attenuated virus vaccine candidate. Virology, 225(2), 419-22, 1996.
Connors, M, Crowe, J E, Firestone, C Y, Murphy, B R, Collins, P L. A cold-passaged, attenuated strain of human respiratory syncytial virus contains mutations in the F and L genes. Virology, 208(2), 478-84, 1995.
Crowe, J E. Current approaches to the development of vaccines against disease caused by respiratory syncytial virus (RSV) and parainfluenza virus (PIV). A meeting report of the WHO Programme for Vaccine Development. Vaccine, 13(4), 415-21, 1995.
Crowe, J E, Bui, P T, Siber, G R, Elkins, W R, Chanock, R M, Murphy, B R. Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization. Vaccine, 13(9), 847-55, 1995.
Hsu, K H, Crowe, J E, Lubeck, M D, Davis, A R, Hung, P P, Chanock, R M, Murphy, B R. Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus. Vaccine, 13(5), 509-15, 1995.
Kulkarni, A B, Collins, P L, Bacik, I, Yewdell, J W, Bennink, J R, Crowe, J E, Murphy, B R. Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus. J Virol, 69(2), 1261-4, 1995. PMCID:188700
Crowe JE Jr, Murphy BR, Chanock RM, Williamson A, Barbas CF III, Burton DR. Human RSV monoclonal antibody Fab cloned from a combinatorial library and produced in E. coli is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Brown F, Chanock RM, Ginsberg HS, Norrby E, eds. Vaccines 94: Modern Approaches to New Vaccines Including Prevention of AIDS. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, , 315-320, 1994.
Crowe, J E, Bui, P T, Davis, A R, Chanock, R M, Murphy, B R. A further attenuated derivative of a cold-passaged temperature-sensitive mutant of human respiratory syncytial virus retains immunogenicity and protective efficacy against wild-type challenge in seronegative chimpanzees. Vaccine, 12(9), 783-90, 1994.
Crowe, J E, Bui, P T, London, W T, Davis, A R, Hung, P P, Chanock, R M, Murphy, B R. Satisfactorily attenuated and protective mutants derived from a partially attenuated cold-passaged respiratory syncytial virus mutant by introduction of additional attenuating mutations during chemical mutagenesis. Vaccine, 12(8), 691-9, 1994.
Crowe, J E, Cheung, P Y, Wallace, E F, Chanock, R M, Larrick, J W, Murphy, B R, Fry, K. Isolation and characterization of a chimpanzee monoclonal antibody to the G glycoprotein of human respiratory syncytial virus. Clin Diagn Lab Immunol, 1(6), 701-6, 1994. PMCID:368396
Crowe, J E, Murphy, B R, Chanock, R M, Williamson, R A, Barbas, C F, Burton, D R. Recombinant human respiratory syncytial virus (RSV) monoclonal antibody Fab is effective therapeutically when introduced directly into the lungs of RSV-infected mice. Proc Natl Acad Sci U S A, 91(4), 1386-90, 1994. PMCID:43163
Murphy BR, Crowe JE Jr, Lubeck MD, Hsu K-HL, Hall SL, Karron RA, Clements ML, Wright PF, Belshe RB, Chanock RM. Live attenuated vaccines for respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV 3). Report of the 104th Ross Conference on Pediatric Research, published by Ross Products, , 173-178, 1994.
Murphy, B R, Hall, S L, Kulkarni, A B, Crowe, J E, Collins, P L, Connors, M, Karron, R A, Chanock, R M. An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines. Virus Res, 32(1), 13-36, 1994.
Chanock, R M, Crowe, J E, Murphy, B R, Burton, D R. Human monoclonal antibody Fab fragments cloned from combinatorial libraries: potential usefulness in prevention and/or treatment of major human viral diseases. Infect Agents Dis, 2(3), 118-31, 1993.
Crowe JE Jr, Barbas CF III, Bui P, Cababa D, Jones TM, Zebedee SL, Murphy BR, Chanock RM, Burton DR. Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity. Brown F, Chanock RM, Ginsberg HS, Lerner RA, eds. Vaccines 93: Modern Approaches to New Vaccines Including Prevention of AIDS. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, (), 7-11, 1993.
Crowe, J E, Collins, P L, London, W T, Chanock, R M, Murphy, B R. A comparison in chimpanzees of the immunogenicity and efficacy of live attenuated respiratory syncytial virus (RSV) temperature-sensitive mutant vaccines and vaccinia virus recombinants that express the surface glycoproteins of RSV. Vaccine, 11(14), 1395-404, 1993.
Barbas, C F, Crowe, J E, Cababa, D, Jones, T M, Zebedee, S L, Murphy, B R, Chanock, R M, Burton, D R. Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity. Proc Natl Acad Sci U S A, 89(21), 10164-8, 1992. PMCID:50298
Murphy BR, Hall SL, Crowe JE Jr, Collins PL, Subbarao EK, Connors M, London WT, Chanock RM. The use of chimpanzees in respiratory virus research. Erwin J, Landon JC, eds. Chimpanzee Conservation and Public Health: Environments for the Future, , 21 28, 1992.
Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Copyright © 2008 Vanderbilt University School of Medicine
The office of Biomedical Research Education & Training All rights reserved.
For questions or problems concerning this page, please submit a help ticket.